FDA-Drug2026-03-04Class IIPROCESSING DEFECT

Vista Meibo Tears eye drops recalled for sterility concerns

OTHERNationwide distributionDrugsBaby & kids

What this means

Vista Meibo Tears Propylene Glycol 0.6% eye drops were not manufactured under proper safety conditions, raising concerns about sterility. The FDA issued a recall of all lots distributed nationwide. No injuries have been reported.

  • Stop using this product immediately.
  • Do not put these eye drops in your eyes.
  • Contact your pharmacist or doctor for safe alternatives.
  • Dispose of the bottle safely.
The agency's original wording
Hazard

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Intended for
All ages
Illnesses reported
None reported
Sold states
Distributed Nationwide in the USA
Affected count
11,520 cartons
Manufactured in
H - 881, N/A, Bhiwadi, N/A, India
Products
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0348-2026

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime